Oral Rimegepant for Preventive Treatment of Migraine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral Rimegepant for Preventive Treatment of Migraine: A Phase 2/3, Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 2020 Dec 15;[EPub Ahead of Print], R Croop, RB Lipton, D Kudrow, DA Stock, L Kamen, CM Conway, EG Stock, V Coric, PJ GoadsbyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.